Symptoms and General Pathology

All Conditions

Nervous System Diseases

Gland and Hormone Related Diseases

Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Syndrome

Pituitary Diseases

Polycystic Ovary Syndrome

Hypothyroidism

Anovulation

Cysts

Ovarian Cysts

Ovarian Diseases

Adnexal Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Gonadal Disorders

Endocrine System Diseases

Hypothalamic Diseases

Brain Diseases

Central Nervous System Diseases

Thyroid Diseases

All Drugs and Chemicals

Reproductive Control Agents

Hormones

Estradiol 17 beta-cypionate

Estradiol 3-benzoate

Estradiol

Polyestradiol phosphate

Comparison of AMH, FSH, LH, estradiol, AFC/ ovarian volume on ultrasound in women in the 4 study arms

Comparison of laboratory test results in women in the 4 study arms

Robert Jach, Prof.

Thyroid hormones (TH) can modify the functioning of the hypothalamic-pituitary-ovarian axis, affecting the functions of granulosa cells and the development and apoptosis of preantral follicles. TH receptors are present within the oocytes, and TH and anti-thyroid antibodies (ATA) are present in the follicular fluid. Improper thyroid function can cause ovulation disorders, luteal phase failure, impaired endometrial receptivity and result in implantation failures and recurrent miscarriages. While overt hypothyroidism is treated to improve fertility, the effect of subclinical hypothyroidism (SCH) and the presence of circulating ATAs on fertility and obstetric outcomes is uncertain and data on ovarian reserve rates are conflicting. Among the causes of ovulation disorders (group II according to the WHO classification), polycystic ovary syndrome (PCOS) dominates, found in 3-15% of women of reproductive age, and the remaining group of causes is the so-called Hypothalamic-Pituitary-Ovarian Axis Dysfunction (HPOD). The exact etiology of both entities is unknown.

Purpose of the study

Evaluation of ovarian reserve indices in women with normogonadotropic anovulation with SCH and without thyroid disease.

Detailed objectives

i) Assessment of AMH, FSH, LH, estradiol, astral follicle count (AFC)/ovarian volume in the subpopulation of women with PCOS and SCH compared to women with PCOS without thyroid disease ii) Assessment of AMH, FSH, LH, estradiol, AFC/ovarian volume in the subpopulation of women with HPOD (other than PCOS) with SCH compared to women with HPOD without thyroid disease iii) Comparison of AMH, FSH, LH, estradiol, AFC/ovarian volume in women with PCOS and HPOD with and without thyroid disease and evaluation of correlation with US ovarian morphology iv) Calculation of the cut-off point of AMH concentration correlating with a high probability of PCOS diagnosis and TSH correlating with unfavorable parameters of ovarian function/HPO axis.

Subclinical Hypothyroidism and Normogonadotropic Anovulation

Subclinical Hypothyroidism and Ovarian Reserve Indices in Women With Normogonadotropic Anovulation

Measurement of serum AMH concentration in women in 4 arms of the study

Measurement of serum FSH, LH, estradiol concentration in women in 4 arms of the study

Ultrasound measurement of AFC/ovarian volume

Jagiellonian University

Principal Investigator

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Subclinical Hypothyroidism and Normogonadotropic Anovulation	NCT05782725	Polycystic Ovar... Hypothalamic-Pi...	Comparison of l...	18 Years - 45 Years	Jagiellonian University
Subclinical Hypothyroidism and Normogonadotropic Anovulation	NCT05782725	Polycystic Ovar... Hypothalamic-Pi...	Comparison of l...	18 Years - 45 Years	Jagiellonian University

Spots Global Cancer Trial Database for comparison of laboratory test results in women in the 4 study arms